Substance-based medical devices made of natural substances: An opportunity for therapeutic innovation
The approval of EU Regulation 2017/745 has created a regulatory framework capable of consolidating an entire category of therapeutic products, that of Substance-based Medical Devices. The Regulation creates the conditions required to promote innovation in therapeutics, both for the so-called "m...
Saved in:
Main Author: | |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_c0dac19361594d8f912c1d4049da5765 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Emiliano Giovagnoni |e author |
700 | 1 | 0 | |a Emiliano Giovagnoni |e author |
245 | 0 | 0 | |a Substance-based medical devices made of natural substances: An opportunity for therapeutic innovation |
260 | |b Frontiers Media S.A., |c 2022-09-01T00:00:00Z. | ||
500 | |a 2674-0869 | ||
500 | |a 10.3389/fdsfr.2022.998114 | ||
520 | |a The approval of EU Regulation 2017/745 has created a regulatory framework capable of consolidating an entire category of therapeutic products, that of Substance-based Medical Devices. The Regulation creates the conditions required to promote innovation in therapeutics, both for the so-called "minor illnesses" as well as for important "unmet medical needs". At the same time, it significantly raises the standards for evaluating their efficacy and safety. Among the different kinds of Substance-based Medical Devices, those made of natural complex substances offer a special opportunity. In this new regulatory context, natural substances can be made available to the patient within an "evidence-based" context, guided by the principles of Systems Biology and Systems Medicine, and under the control of the healthcare sector. Substance-based Medical Devices are already an important product in the European therapeutic market and will likely play an increasing role in the years to come. | ||
546 | |a EN | ||
690 | |a substance-based medical device | ||
690 | |a medical devices made of substances | ||
690 | |a natural substances | ||
690 | |a innovation | ||
690 | |a herbal medicines | ||
690 | |a medical device regulation | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Frontiers in Drug Safety and Regulation, Vol 2 (2022) | |
787 | 0 | |n https://www.frontiersin.org/articles/10.3389/fdsfr.2022.998114/full | |
787 | 0 | |n https://doaj.org/toc/2674-0869 | |
856 | 4 | 1 | |u https://doaj.org/article/c0dac19361594d8f912c1d4049da5765 |z Connect to this object online. |